文献速递糖尿病肥胖与代谢综合征

减重手术与生活方式干预治疗糖尿病:随机试验5年结局

Bariatric Surgery vs Lifestyle Intervention for Diabetes Treatment: 5-Year Outcomes From a Randomized Trial.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

在美国匹兹堡大学开展的随机对照试验,61例肥胖合并2型糖尿病患者初始随机接受Roux-en-Y胃旁路术、腹腔镜可调节胃束带术或强化生活方式减重干预1年,随后4年接受低强度生活方式干预。5年时部分或完全缓解率手术组高于生活方式组,且RYGB组体重降幅最大。

要点

  • 5年2型糖尿病部分或完全缓解率:RYGB组30%(n=6)、LAGB组19%(n=4)、LWLI组0%(P=0.0208)。
  • 5年无需任何降糖药物比例:RYGB组56%、LAGB组45%、LWLI组0%(P=0.0065)。
  • 5年平均体重降幅:RYGB组25.2%±2.1%、LAGB组12.7%±2.0%、生活方式组5.1%±2.5%(两两比较P<0.01)。

核心结论

  • 对于肥胖合并2型糖尿病患者,手术治疗比单独生活方式干预更有效。

研究设计与样本

  • 美国匹兹堡大学开展的随机对照试验,61例肥胖合并2型糖尿病患者初始随机接受Roux-en-Y胃旁路术(RYGB)、腹腔镜可调节胃束带术(LAGB)或强化生活方式减重干预(LWLI)1年,随后4年接受低强度生活方式减重干预(LLLI)。
  • 随访5年,时间为2015年2月至2016年6月。

主要发现

  • 患者平均年龄47±6.6岁,82%为女性,21%为非裔美国人;平均糖化血红蛋白7.8%±1.9%,平均体重指数(BMI)35.7±3.1 kg/m2,26例(43%)BMI<35 kg/m2。
  • 5年时部分或完全2型糖尿病缓解率:RYGB组30%(n=6)、LAGB组19%(n=4)、LWLI组0%(P=0.0208)。
  • 5年时无需任何2型糖尿病药物比例:RYGB组56%、LAGB组45%、LWLI组0%(P=0.0065)。
  • 5年平均体重降幅:RYGB组25.2%±2.1%、LAGB组12.7%±2.0%、生活方式组5.1%±2.5%(两两比较P<0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Questions remain about bariatric surgery for type 2 diabetes mellitus (T2DM) treatment. OBJECTIVE: Compare the remission of T2DM following surgical or nonsurgical treatments. DESIGN, SETTING, AND PARTICIPANTS: Randomized controlled trial at the University of Pittsburgh, in the United States. Five-year follow-up from February 2015 until June 2016. INTERVENTIONS: 61 participants with obesity and T2DM who were initially randomized to either bariatric surgical treatments (Roux-en-Y gastric bypass [RYGB] or laparoscopic adjustable gastric banding [LAGB]) or an intensive lifestyle weight loss intervention (LWLI) program for 1 year. Lower level lifestyle weight loss interventions (LLLIs) were then delivered for 4 years. MAIN OUTCOMES AND MEASURES: Diabetes remission assessed at 5 years. RESULTS: The mean age of the patients was 47 ± 6.6 years, 82% were women, and 21% African American. Mean hemoglobin A1c level 7.8% ± 1.9%, body mass index (BMI) 35.7 ± 3.1 kg/m2, and 26 participants (43%) had BMI < 35 kg/m2. Partial or complete T2DM remission was achieved by 30% (n = 6) of RYGB, 19% (n = 4) of LAGB, and no LWLI participants (P = .0208). At 5 years those in the RYGB group had the largest percentage of individuals (56%) not requiring any medications for T2DM compared with those in the LAGB (45%) and LWLI (0%) groups (P = .0065). Mean reductions in percent body weight at 5 years was the greatest after RYGB 25.2% ± 2.1%, followed by LAGB 12.7% ± 2.0% and lifestyle treatment 5.1% ± 2.5% (all pairwise P < .01). CONCLUSIONS: Surgical treatments are more effective than lifestyle intervention alone for T2DM treatment.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Courcoulas AP, Gallagher JW, Neiberg RH, et al. Bariatric Surgery vs Lifestyle Intervention for Diabetes Treatment: 5-Year Outcomes From a Randomized Trial. J Clin Endocrinol Metab. 2020. PMID: 31917447. doi:10.1210/clinem/dgaa006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。